Muscle Wasting Disorders Market 2024 - By Size, Share, Growth And Global Forecast Report 2033

The muscle wasting disorders market size has grown rapidly in recent years. It will grow from $12.91 billion in 2023 to $15.06 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to increasing aging population, rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, emerging therapeutic approaches.

The muscle wasting disorders market size is expected to see rapid growth in the next few years. It will grow to $26.11 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to regulatory support, patient advocacy initiatives, healthcare infrastructure development, globalization of clinical trials, personalized medicine approaches. Major trends in the forecast period include telemedicine adoption, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, biopharmaceutical innovation.

Market Overview -
Muscle wasting disorders, or muscle atrophy or muscle wasting, refer to a condition characterized by a diverse group of conditions that cause the progressive loss of muscle mass and strength. This can occur as a result of various factors, including disuse, aging, malnutrition, neurodegenerative diseases, and certain medical conditions.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market
Rising adherence to a sedentary lifestyle is expected to propel the growth of the muscle wasting disorders market going forward. A sedentary lifestyle refers to a lifestyle in which an individual is physically inactive and engages in little or no physical movement or exercise. Sedentary behavior can negatively impact muscle function, leading to a decline in muscle strength and endurance, contributing to muscle wasting disorders, and making it more difficult for individuals to maintain their muscle mass and function. For instance, in 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, over 80% of adolescents and 27% of adults did not adhere to the physical activity levels recommended by the World Health Organization. Therefore, rising adherence to a sedentary lifestyle is driving the growth of the muscle wasting disorders market.

Competitive Landscape -
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG , Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix , MyoKardia, Inc., MyoTherix Inc.

Innovative Advancements In The Muscle Wasting Disorders Market
Major companies operating in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients with muscle wasting disorders. Novel gene therapy refers to a medical technology that aims to produce a therapeutic effect through the manipulation of gene expression or altering the biological properties of living cells. For instance, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, introduced Elevidys, which is the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy designed to deliver into the body a gene that leads to a shortened protein that contains selected domains of the dystrophin protein of normal muscle cells. The product is administered as a single intravenous infusion.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Key Segments -
The muscle wasting disorders market covered in this report is segmented -
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.